GO:1990113 RNA polymerase I assembly: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990113 (RNA polymerase I assembly) describes the aggregation, arrangement and bonding of components to form the eukaryotic RNA polymerase I complex, the enzyme dedicated to ribosomal RNA synthesis.
• Assembly is a dynamic, multi-step process involving the association of core subunits, accessory factors, and transient assembly intermediates that modulate rDNA transcription.
• The RNA polymerase I complex comprises 14 subunits in yeast and 14 in humans, with additional accessory factors such as Rrn3, UAF, and TAF1B required for initiation and assembly [1,4].
• Dysregulation of RNA polymerase I assembly and function is linked to cancer, ribosomopathies, and developmental disorders, making it a therapeutic target [3,7].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of assembly factor requirements and disease-associated mutations [2,3].
• Studying RNA polymerase I assembly requires integrated approaches including proteomics, live-cell imaging, and ribosome profiling to capture dynamic assembly intermediates [5,6].
Description
RNA polymerase I assembly (GO:1990113) is the biological process by which the eukaryotic RNA polymerase I complex is built from its constituent subunits and accessory factors. This process is essential for the production of ribosomal RNA (rRNA), which constitutes the majority of cellular RNA and is required for ribosome biogenesis and protein synthesis. Unlike RNA polymerases II and III, RNA polymerase I is dedicated to transcribing the large ribosomal RNA precursor, and its assembly is tightly regulated to match cellular growth demands [4,6]. Understanding the molecular details of RNA polymerase I assembly is critical because defects in this process impair ribosome production and have been implicated in human diseases including cancer and ribosomopathies [3,7]. Recent studies have revealed that assembly is not a simple one-step event but involves dynamic intermediates and quality-control mechanisms that ensure proper complex formation. Moreover, the assembly process is influenced by post-translational modifications and interacting proteins that modulate polymerase I activity [3,5]. This article synthesizes current knowledge on the definition, mechanism, key genes, disease relevance, and research methods for studying RNA polymerase I assembly, providing a comprehensive resource for researchers.
RNA polymerase I assembly At A Glance
| GO ID | GO:1990113 |
|---|---|
| GO term | RNA polymerase I assembly |
| Ontology | biological_process |
| Synonym | DNA-directed RNA polymerase I complex assembly; RNA Polymerase I complex assembly |
| Major function | Formation of the eukaryotic RNA polymerase I complex, enabling ribosomal RNA synthesis |
| Related cellular component | RNA polymerase I complex (nucleus, nucleolus) |
| Related molecular function | DNA-directed 5'-3' RNA polymerase activity; transcription initiation |
| Process context | Ribosome biogenesis; rRNA transcription |
What Is GO:1990113?
According to the Gene Ontology, RNA polymerase I assembly (GO:1990113) is defined as the aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase I complex. This encompasses the assembly of the multi-subunit enzyme from newly synthesized or pre-existing subunits, including the incorporation of accessory factors required for its catalytic activity and regulation. The process ensures that a functional RNA polymerase I holoenzyme is available to transcribe ribosomal DNA into ribosomal RNA.
Why Is RNA polymerase I assembly Important in Cell Biology?
RNA polymerase I assembly is fundamental to cellular growth and proliferation because it produces the enzyme responsible for synthesizing ribosomal RNA, which is the rate-limiting step in ribosome biogenesis. Dysregulation of this assembly process leads to altered rRNA levels, nucleolar stress, and has been directly linked to oncogenic transformation and cancer progression [3,7]. Furthermore, mutations affecting assembly factors cause ribosomopathies and developmental defects, highlighting its clinical relevance. Studying RNA polymerase I assembly also provides insights into general principles of multi-subunit complex assembly and nuclear organization [4,6].
• Essential for ribosomal RNA synthesis and ribosome biogenesis, impacting global protein translation.
• Dysregulation is associated with uncontrolled proliferation in breast cancer and other malignancies.
• Mutations in assembly-related genes cause ribosomopathies such as Treacher Collins syndrome and Diamond-Blackfan anemia.
• Assembly intermediates serve as regulatory checkpoints that coordinate growth signals with rRNA production.
• Provides a target for therapeutic intervention in cancer, as inhibiting RNA polymerase I assembly can selectively affect cancer cells.
• Involved in the cellular response to stress, including nucleolar stress and DNA damage.
• Required for normal development, as knockout of core subunits is embryonic lethal in model organisms.
• Assembly factors are conserved from yeast to humans, enabling cross-species studies.
• Post-translational modifications of subunits regulate assembly and activity.
• Understanding assembly mechanisms aids in interpreting disease-associated mutations.
What Happens During RNA polymerase I assembly?
Subunit synthesis and import into the nucleolus
In simple terms: The building blocks of RNA polymerase I are made in the cytoplasm and then moved into the nucleolus, the factory where assembly happens.
The 14 subunits of RNA polymerase I are synthesized in the cytoplasm and imported into the nucleus, specifically targeting the nucleolus, the site of rRNA transcription and ribosome assembly. This import is mediated by nuclear localization signals and requires energy. Once in the nucleolus, subunits are available for assembly. The process is co-translational for some subunits, as suggested by studies in yeast and human cells. Proper folding and modification of subunits, such as phosphorylation, occur before or during import.
Formation of subcomplexes and intermediate assembly states
In simple terms: The subunits do not all come together at once; they first form smaller groups that later combine into the full enzyme.
Assembly proceeds through distinct subcomplexes. For example, the two largest subunits, RPA190 and RPA135 in yeast (orthologs of human POLR1A and POLR1B), form a core subcomplex that then associates with smaller subunits. Studies using affinity purification and mass spectrometry have identified intermediate complexes containing RPA190, RPA135, and RPA40, among others. These intermediates are dynamic and can be modulated by assembly factors. The yeast upstream activation factor (UAF) interacts with the polymerase I complex and influences its topology during assembly. In humans, the assembly of the pre-initiation complex involves the transcription initiation factor Rrn3 (TIF-IA) and TAF1B.
Incorporation of accessory factors and holoenzyme formation
In simple terms: Helper proteins join the core enzyme to make it fully functional and ready to start transcription.
The core polymerase I subunits assemble into a catalytic core, but full activity requires accessory factors. In yeast, the Rrn3 protein binds to the polymerase I complex and is essential for recruitment to the rDNA promoter. The UAF complex, composed of Rrn5, Rrn9, Rrn10, Uaf30, and histones H3/H4, interacts with the upstream element of the rDNA promoter and with the polymerase I complex, influencing assembly and initiation. In plants, RNA polymerase I holoenzymes include additional subunits that may play regulatory roles. The assembly of the holoenzyme is a prerequisite for transcription initiation and is regulated by growth signals.
Quality control and dynamic remodeling
In simple terms: The cell checks that the assembled enzyme is correct and can disassemble or remodel it if needed.
Assembly is monitored by quality-control mechanisms that ensure only properly assembled complexes are active. Misfolded or misassembled subunits are targeted for degradation. Recent work has shown that K63-linked ubiquitination of RNA polymerase I subunits by DCAF13 regulates assembly and activity, promoting uncontrolled proliferation in breast cancer. Additionally, the assembly of distinct RNA polymerase I complexes modulates rDNA transcription in response to cellular conditions. The dynamic nature of these complexes allows for rapid adaptation to stress and growth signals.
Regulation by post-translational modifications
In simple terms: Chemical tags added to the enzyme's parts can turn assembly on or off.
Post-translational modifications, including phosphorylation and ubiquitination, regulate RNA polymerase I assembly. For instance, phosphorylation of the largest subunit POLR1A affects its interaction with assembly factors. Ubiquitination by DCAF13 promotes the assembly of active polymerase I complexes and is linked to cancer. In yeast, phosphorylation of Rrn3 regulates its association with the polymerase I complex in response to nutrient availability. These modifications provide a layer of control that couples assembly to cellular signaling pathways.
Key Genes Involved in GO:1990113 RNA polymerase I assembly
The following genes encode subunits and accessory factors critical for RNA polymerase I assembly, as identified in eukaryotic models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR1A (RPA190) | Largest subunit; catalytic core; forms subcomplex with POLR1B | Mutations linked to ribosomopathies; target for assembly studies |
| POLR1B (RPA135) | Second largest subunit; catalytic core; interacts with POLR1A | Essential for assembly; knockout lethal in models |
| POLR1C (RPA40) | Common subunit with RNA polymerase III; involved in early assembly | Mutations cause Treacher Collins syndrome |
| POLR1D (RPA20) | Shared subunit; stabilizes core complex | Disease-associated mutations affect assembly |
| POLR1E (RPA49) | Accessory subunit; regulates transcription elongation | Influences assembly dynamics |
| POLR1F (RPA43) | Subunit required for initiation; interacts with Rrn3 | Key for holoenzyme formation |
| POLR1G (RPA34) | Subunit involved in transcription initiation | Potential target for assembly inhibition |
| POLR1H (RPA12) | Small subunit; contributes to catalytic activity | Assembly intermediate component |
| RRN3 (TIF-IA) | Essential initiation factor; bridges polymerase I and promoter | Regulated by phosphorylation; knockout lethal |
| TAF1B | TATA-binding protein-associated factor; part of SL1 complex | Required for recruitment and assembly |
| UAF30 | Component of upstream activation factor; modulates assembly | Influences polymerase I topology |
| RRN5 | UAF subunit; binds upstream element | Assembly and initiation regulation |
| RRN9 | UAF subunit; interacts with Rrn5 and Rrn10 | Assembly factor |
| RRN10 | UAF subunit; stabilizes UAF complex | Assembly and transcription |
| DCAF13 | E3 ubiquitin ligase; mediates K63-linked ubiquitination of Pol I | Promotes assembly and cancer proliferation |
| POLR1A mutant | Altered assembly and rRNA processing | Used to study rDNA stability |
How Is RNA polymerase I assembly Regulated?
RNA polymerase I assembly is regulated at multiple levels to match cellular growth and stress conditions. Growth factor signaling through the mTOR pathway promotes assembly by enhancing the expression and phosphorylation of assembly factors such as Rrn3. Nutrient availability controls the association of Rrn3 with the polymerase I complex, thereby regulating holoenzyme formation. Post-translational modifications, including ubiquitination by DCAF13, directly modulate assembly and activity. Additionally, the assembly of distinct polymerase I complexes in response to environmental cues allows for dynamic regulation of rDNA transcription. Dysregulation of these regulatory mechanisms contributes to diseases such as cancer.
RNA polymerase I assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLR1C | Treacher Collins syndrome | Knockout or point mutation in human cell lines; zebrafish model |
| POLR1D | Treacher Collins syndrome | CRISPR knock-in of patient mutations in iPSCs |
| DCAF13 | Breast cancer | Overexpression and knockout in breast cancer cell lines; xenograft |
| POLR1A | Ribosomopathy, cancer | Point mutation knock-in in HEK293; patient-derived organoids |
| RRN3 | Developmental disorders | Conditional knockout in mouse models |
Cancer
Dysregulation of RNA polymerase I assembly and activity is a hallmark of cancer. In breast cancer, DCAF13-mediated K63-linked ubiquitination of RNA polymerase I promotes assembly and uncontrolled proliferation, suggesting that targeting this modification could be therapeutic. Elevated rRNA synthesis due to increased assembly supports the high metabolic demands of cancer cells. Inhibitors of RNA polymerase I transcription, such as CX-5461, are in clinical trials and indirectly affect assembly.
Ribosomopathies
Mutations in genes encoding RNA polymerase I subunits or assembly factors cause ribosomopathies, a group of disorders characterized by defective ribosome biogenesis. For example, mutations in POLR1C and POLR1D are associated with Treacher Collins syndrome, a craniofacial developmental disorder. These mutations impair assembly and reduce rRNA synthesis, leading to nucleolar stress and p53 activation.
Neurodegeneration and aging
Altered RNA polymerase I assembly and rRNA transcription have been linked to aging and neurodegenerative diseases. In yeast, mutations affecting polymerase I assembly lead to rDNA instability and shortened replicative lifespan. In mammals, nucleolar stress caused by defective assembly can trigger neurodegenerative pathways, although direct evidence is still emerging.
From RNA polymerase I assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of POLR1A in assembly? | CRISPR knockout of POLR1A in HeLa cells followed by proteomics |
| How do disease mutations affect assembly? | Point mutation knock-in of POLR1C mutations in iPSCs |
| Does DCAF13-mediated ubiquitination regulate assembly? | Knockout of DCAF13 in breast cancer cells; overexpression of ubiquitin mutants |
| What are the dynamic assembly intermediates? | Tagged knock-in of POLR1A with GFP for live-cell imaging |
| Can overexpression of RRN3 drive proliferation? | Overexpression of RRN3 in primary fibroblasts |
| What is the effect of assembly factor loss on rRNA synthesis? | Knockout of UAF30 in yeast; RNA-seq and Ribo-seq |
How to Study the RNA polymerase I assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein-protein interactions and assembly intermediates | Identifying subunits and assembly factors |
| Ribo-seq | Global translation efficiency | Assessing impact of assembly defects on protein synthesis |
| RNA-seq | rRNA precursor processing and mature rRNA levels | Quantifying rRNA synthesis |
| Live-cell imaging | Subcellular localization and dynamics of tagged subunits | Visualizing assembly in real time |
| CRISPR screen | Genes required for assembly or rRNA transcription | Discovery of novel assembly factors |
| ChIP-seq | DNA binding of polymerase I at rDNA | Mapping initiation sites |
| Proximity labeling | Interactome of assembly factors | Identifying transient interactions |
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) is used to identify assembly intermediates and interacting partners of RNA polymerase I. For example, Torreira et al. used cross-linking mass spectrometry to reveal dynamic assembly of distinct RNA polymerase I complexes. Piñeiro et al. identified the RNA interactome of RNA polymerase I using RNA immunoprecipitation. These methods provide snapshots of assembly states.
Live-cell imaging
Fluorescent tagging of polymerase I subunits, such as GFP-POLR1A, allows real-time visualization of assembly in living cells. This approach can reveal the kinetics of subunit incorporation and the formation of subnuclear foci. Studies in yeast have used live-cell imaging to track UAF and polymerase I dynamics.
Ribosome profiling and RNA-seq
Ribosome profiling (Ribo-seq) measures global translation, while RNA-seq quantifies rRNA precursors and mature rRNA levels. These methods assess the functional consequences of assembly defects. For instance, Normand et al. used RNA-seq to show that a polymerase I mutant affects rRNA processing and rDNA stability.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for RNA polymerase I assembly and function. Such screens have uncovered novel assembly factors and modifiers. Combined with bioinformatics, these screens link genotype to rRNA transcription phenotypes.
How CRISPR Can Be Used to Study GO:1990113 RNA polymerase I assembly
Knockout
CRISPR knockout of core RNA polymerase I subunits (e.g., POLR1A, POLR1B) is lethal in most cell types, but conditional or inducible knockout systems allow studying assembly defects. Knockout of accessory factors like RRN3 or UAF components impairs assembly and reduces rRNA synthesis, providing models for ribosomopathies. These models are used to dissect the requirement for specific subunits in assembly.
Point Mutation
Point mutations identified in patients with ribosomopathies (e.g., POLR1C mutations) can be introduced into cell lines using CRISPR base editing or homology-directed repair. Such models reveal how specific amino acid changes affect subunit folding, interactions, and assembly efficiency. They are valuable for testing targeted therapies.
Knock-in
Knock-in of fluorescent or affinity tags (e.g., GFP, HA) into endogenous polymerase I subunit genes enables visualization and purification of assembly intermediates. Tagged knock-in models are used for live-cell imaging and proteomics to track assembly dynamics. Additionally, knock-in of disease-associated mutations creates isogenic models for studying pathogenesis.
Overexpression
Overexpression of assembly factors such as RRN3 or DCAF13 can drive increased assembly and rRNA synthesis, promoting proliferation. This approach is used to model cancer-associated upregulation of RNA polymerase I activity. Conversely, overexpression of dominant-negative subunits can disrupt assembly and serve as a tool to inhibit rRNA transcription.
How EDITGENE Supports RNA polymerase I assembly Research
Researchers studying RNA polymerase I assembly-related genes often need to determine whether a candidate gene is causally involved in the assembly process, how specific mutations affect complex formation, and whether modulating its expression alters rRNA synthesis and cellular phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase I assembly research.
Frequently Asked Questions About RNA polymerase I assembly
What is RNA polymerase I assembly?
RNA polymerase I assembly (GO:1990113) is the process of building the eukaryotic RNA polymerase I complex from its subunits and accessory factors, enabling ribosomal RNA synthesis.
What genes are involved in RNA polymerase I assembly?
Key genes include POLR1A, POLR1B, POLR1C, POLR1D, POLR1E, POLR1F, POLR1G, POLR1H, RRN3, TAF1B, UAF30, RRN5, RRN9, RRN10, and DCAF13 [1,3,4].
Why is RNA polymerase I assembly important?
It is essential for ribosomal RNA production and ribosome biogenesis, and its dysregulation is linked to cancer and ribosomopathies [3,7].
How is RNA polymerase I assembly regulated?
It is regulated by growth signaling pathways (e.g., mTOR), post-translational modifications such as ubiquitination and phosphorylation, and assembly factors like Rrn3 [3,4].
What diseases are associated with defects in RNA polymerase I assembly?
Defects are associated with Treacher Collins syndrome, other ribosomopathies, and various cancers including breast cancer [3,7].
What methods are used to study RNA polymerase I assembly?
Common methods include affinity purification-mass spectrometry, live-cell imaging, RNA-seq, Ribo-seq, and CRISPR screens [2,5,6].
Can CRISPR be used to study RNA polymerase I assembly?
Yes, CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models are powerful tools to dissect assembly mechanisms and disease mutations [2,3].
What are the assembly intermediates of RNA polymerase I?
Assembly proceeds through subcomplexes containing core subunits like POLR1A and POLR1B, which then associate with smaller subunits and accessory factors such as Rrn3 and UAF [1,6].
How does DCAF13 regulate RNA polymerase I assembly?
DCAF13 mediates K63-linked ubiquitination of RNA polymerase I, promoting assembly and uncontrolled proliferation in breast cancer.
What is the role of RRN3 in RNA polymerase I assembly?
RRN3 (TIF-IA) is an essential initiation factor that binds to the polymerase I complex and is required for recruitment to the rDNA promoter, thus playing a key role in holoenzyme formation.
Conclusion
RNA polymerase I assembly (GO:1990113) is a dynamic and highly regulated process essential for ribosomal RNA synthesis and cellular growth. Advances in proteomics, imaging, and CRISPR-based genetics have illuminated the stepwise assembly of the polymerase I complex and its accessory factors. Dysregulation of this process contributes to cancer and ribosomopathies, making it a compelling target for therapeutic intervention. Continued research using precise gene-editing models will further unravel the molecular details and disease connections of RNA polymerase I assembly.
References
- 1. Knutson BA et al.. 2020. Molecular Topology of RNA Polymerase I Upstream Activation Factor.. Mol Cell Biol 40(13) PMID: 32253346
- 2. Normand C et al.. 2024. RNA polymerase I mutant affects ribosomal RNA processing and ribosomal DNA stability.. RNA Biol 21(1):1-16 PMID: 39049162
- 3. Yang ZZ et al.. 2025. DCAF13-mediated K63-linked ubiquitination of RNA polymerase I promotes uncontrolled proliferation in Breast Cancer.. Nat Commun 16(1):557 PMID: 39788980
- 4. Turowski TW et al.. 2021. Specific Features of RNA Polymerases I and III: Structure and Assembly.. Front Mol Biosci 8:680090 PMID: 34055890
- 5. Piñeiro D et al.. 2018. Identification of the RNA polymerase I-RNA interactome.. Nucleic Acids Res 46(20):11002-11013 PMID: 30169671
- 6. Torreira E et al.. 2017. The dynamic assembly of distinct RNA polymerase I complexes modulates rDNA transcription.. Elife 6 PMID: 28262097
- 7. Hannan KM et al.. 2013. Dysregulation of RNA polymerase I transcription during disease.. Biochim Biophys Acta 1829(3-4):342-60 PMID: 23153826
- 8. Kenzior A et al.. 2001. RNA polymerase I holoenzymes.. Trends Plant Sci 6(3):87-8 PMID: 11239591
